VELA ACQUISITION CORP has a total of 12 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are GENKYOTEX SA, TIANJIN TIANSHILI PHARMACEUTIC and INTRACELLULAR THERAPIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | United States | 2 | |
#3 | Canada | 1 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Kucharik Robert F | 8 |
#2 | Harris Herbert W | 6 |
#3 | Leventer Steven M | 5 |
#4 | Ye Naidong | 2 |
#5 | Perrin Scott R | 2 |
#6 | Galbraith Kimm B | 2 |
#7 | Hauck Wilhelm | 2 |
#8 | Galbraith Kimm | 1 |
#9 | Ye Naidaong | 1 |
#10 | Ravi Mallikarjun Reddy | 1 |
Publication | Filing date | Title |
---|---|---|
US2006264421A1 | Conversion process for 2,3-benzodiazepine enantiomers | |
EP1689408A1 | Treatment of inflammatory disorders of the epithelium with low dose 2,3-benzodiazepines | |
US2004157833A1 | Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and uses thereof |